This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Review

. 1989 Dec;60(6):807-8.

doi: 10.1038/bjc.1989.370.

5-Fluorouracil and folinic acid: interesting biochemistry or effective treatment?

D J Kerr

PMID: 2690911
PMCID: PMC2247260
DOI: 10.1038/bjc.1989.370

Free PMC article

Review

5-Fluorouracil and folinic acid: interesting biochemistry or effective treatment?

D J Kerr. Br J Cancer. 1989 Dec.

Free PMC article

. 1989 Dec;60(6):807-8.

doi: 10.1038/bjc.1989.370.

Author

D J Kerr

PMID: 2690911
PMCID: PMC2247260
DOI: 10.1038/bjc.1989.370

No abstract available

PubMed Disclaimer

Comment in

The cost of folinic acid.
Healy JB. Healy JB. Br J Cancer. 1990 Sep;62(3):467. doi: 10.1038/bjc.1990.320. Br J Cancer. 1990. PMID: 2206957 Free PMC article. No abstract available.

Similar articles

5-Fluorouracil and folinic acid: summary of clinical experience.
Creaven PJ. Creaven PJ. Adv Exp Med Biol. 1988;244:303-11. doi: 10.1007/978-1-4684-5607-3_33. Adv Exp Med Biol. 1988. PMID: 3073664 Clinical Trial. No abstract available.
5-Fluorouracil (FUra) and folinic acid (FA) therapy in patients with colorectal cancer.
Erlichman C. Erlichman C. Adv Exp Med Biol. 1988;244:185-92. doi: 10.1007/978-1-4684-5607-3_19. Adv Exp Med Biol. 1988. PMID: 3073653 Clinical Trial. No abstract available.
[Irinotecan plus fluorouracil and folinic acid in metastatic colorectal cancer].
Krieger G. Krieger G. Strahlenther Onkol. 2001 Jun;177(6):316-8. Strahlenther Onkol. 2001. PMID: 11446323 German. No abstract available.
Oxaliplatin. A review of its pharmacological properties and clinical efficacy in metastatic colorectal cancer and its potential in other malignancies.
Culy CR, Clemett D, Wiseman LR. Culy CR, et al. Drugs. 2000 Oct;60(4):895-924. doi: 10.2165/00003495-200060040-00005. Drugs. 2000. PMID: 11085200 Review.
Recommendation for irinotecan, 5-fluorouracil, and leucovorin as first-line therapy for colorectal cancer.
Fisher MD. Fisher MD. Clin Colorectal Cancer. 2001 Aug;1(2):82-4. doi: 10.1016/S1533-0028(11)70541-2. Clin Colorectal Cancer. 2001. PMID: 12445364 Review. No abstract available.

See all similar articles

Cited by

The cost of folinic acid.
Healy JB. Healy JB. Br J Cancer. 1990 Sep;62(3):467. doi: 10.1038/bjc.1990.320. Br J Cancer. 1990. PMID: 2206957 Free PMC article. No abstract available.
Clinical pharmacokinetic advantages of new drug delivery methods for the treatment of liver tumours.
Anderson JH, Warren HW, McArdle CS. Anderson JH, et al. Clin Pharmacokinet. 1994 Sep;27(3):191-201. doi: 10.2165/00003088-199427030-00003. Clin Pharmacokinet. 1994. PMID: 7988101 Review.
Disposition of 5-formyl- and 5-methyltetrahydrofolic acid in serum after i.v. bolus of calcium folinate: pharmacokinetic drug interaction with preadministered interferon-alpha-2b.
Czejka MJ, Schüller J, Weiss C, Bandak S, Meyer B, Simon D. Czejka MJ, et al. Eur J Drug Metab Pharmacokinet. 1995 Oct-Dec;20(4):255-62. doi: 10.1007/BF03190241. Eur J Drug Metab Pharmacokinet. 1995. PMID: 8983929
Paradoxical effects of 5-FU/folinic acid on lymphokine-activated killer (LAK) cell induction in patients with colorectal cancer.
Onodera H, Somers SS, Guillou PJ. Onodera H, et al. Br J Cancer. 1990 Dec;62(6):1042-6. doi: 10.1038/bjc.1990.436. Br J Cancer. 1990. PMID: 2257211 Free PMC article.
A pharmacokinetic comparison of intravenous versus intra-arterial folinic acid.
Anderson JH, Kerr DJ, Setanoians A, Cooke TG, McArdle CS. Anderson JH, et al. Br J Cancer. 1992 Jan;65(1):133-5. doi: 10.1038/bjc.1992.26. Br J Cancer. 1992. PMID: 1733436 Free PMC article. Clinical Trial.

See all "Cited by" articles

References

1. Cancer Res. 1981 Sep;41(9 Pt 1):3288-95 - PubMed
1. Eur J Cancer Clin Oncol. 1982 Apr;18(4):347-54 - PubMed
1. J Clin Oncol. 1986 May;4(5):685-96 - PubMed
1. J Clin Oncol. 1989 Apr;7(4):425-32 - PubMed
1. J Clin Oncol. 1989 Apr;7(4):471-6 - PubMed

Publication types

Actions
Actions
Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions

LinkOut - more resources

Full Text Sources